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Background and aims: Some form of gambling can be observed in nearly every society, as the gratiﬁcation felt upon
winning in uncertain conditions is universal. A culturally distinct form of gambling, associated with a traditional
sporting event of archery known as “teer,” is innate to the province of Meghalaya, India. The objective of this study
was to ﬁnd genetic variants underlying this unique form of behavioral addiction. To better understand game-based
gambling, we studied genetic variants related to dopaminergic pathways and other genes previously linked to various
psychological disorders. Methods: This study was carried out on a sample of 196 Indo-Aryan adults from Shillong,
Meghalaya. Genotyping of glial cell line-derived neurotrophic factor (GDNF) polymorphisms was carried out using
real-time PCR. We further investigated 32 single nucleotide polymorphisms located in the 3′UTR of additional genes
of interest using an OpenArray® real-time PCR platform. Results: Case–control analysis revealed a signiﬁcant
association between GDNF variant rs2973033 (p= .00864, χ2= 13.132, df= 2) and contactin-associated protein-like
2 (CNTNAP2) variant rs2530311 (p= .0448, χ2= 13.132, df= 2) with gambling. Discussion and conclusions:
Association of the GDNF gene with gambling could be attributed to its involvement in the development and survival
of dopaminergic neurons. Our result is in good agreement with previous data indicating the role of GDNF in certain
substance addictions. Several rare variants in the CNTNAP2 gene were also implicated in alcohol addiction in a
previous study. This pilot study provides further support for the role of GDNF and CNTNAP2 in addiction behaviors.
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INTRODUCTION
Substance-related and addictive disorders are conditions
characterized using different classes of drugs that produce
reward when used in excess, as deﬁned by the ﬁfth edition of
Diagnostic and Statistical Manual of Mental Disorders
(DSM-5; American Psychiatric Association, 2013). Game-
based gambling is considered a prototypical example of
behavioral (non-substance) addiction (Robbins & Clark,
2015) in the DSM-5. It is known that about 70%–90% of
people gamble at some time in their lives (Shaffer, Hall, &
Vander Bilt, 1999; Welte, Barnes, Tidwell, Hoffman, &
Wieczorek, 2015); however, only a small portion (1%–2%)
will develop a gambling disorder (Xuan et al., 2017).
Gambling involves wagering money or other valuable
objects on an event where the outcome is not certain. Thus,
gambling implies the willingness to risk something valuable
with the hope of a reward. Excessive gambling, however,
can lead to negative consequences in subjective well-being
by affecting several aspects of daily life, such as mental
state, behavior, economy, and relationships. Symptoms are
very similar to those observed in substance use dependence
(Grant, Potenza, Weinstein, & Gorelick, 2010).
This study was conducted on participants practicing a
distinct form of gambling related to the game of archery. In
the region of Meghalaya, India, archery (called “teer”) is a
traditional game among the Khasi population. This sport has
been legalized by the local government of Meghalaya and
takes place twice a day in the capital city of Shillong. Within
a designated arena, a group of professional archers aim and
shoot hundreds of arrows at a target. Spectators bid on the
last two digits (between 00 and 99) of the total number of
arrows that will hit the target. Government-registered coun-
ters are spread across the city, and it is here that gamblers
buy their tickets with the preferred two-digit number.
Following the tournament, individuals who had bid the
right guess may collect their prize money from the counters.
Despite being a traditional Khasi sport, “teer” has gained so
much popularity recently that other communities of Shillong
also take part in this particular form of game-based gamble.
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Therefore, this pilot study was performed on a unique,
culturally distinct phenotype, where even collection of the
sample was a great challenge and as such it should be
considered as an exploratory analysis.
Genetic studies of gambling behavior are sparse in
literature (Gyollai et al., 2014). In this study conducted on
the Indo-Aryan population from Shillong, we mainly focused
on glial cell line-derived neurotrophic factor (GDNF), a gene
involved in dopaminergic neuronal development, which has
previously been found to be associated with methamphetamine
(Yoshimura et al., 2011) and tobacco addiction (Kotyuk et al.,
2016). In order to investigate the possible role of epigenetic
regulation of gene expression in gambling, different single
nucleotide polymorphisms (SNPs) located in 3′ untranslated
regions (3′ UTRs) of additional candidate genes associated
with gambling, such as catechol-O-methyltransferase (Grant,
Potenza, Weinstein, & Gorelick, 2015; Guillot, Fanning,
Liang, & Berman, 2015; Verdejo-Garcia et al., 2013), DRD2
(Fagundo et al., 2014; Hillemacher et al., 2016; Joutsa et al.,
2014), GDNF (Kotyuk et al., 2016; Ron & Janak, 2005),
monoamine oxidase A (Ibanez et al., 2000), and solute carrier
family 6 member 3 (Fagundo et al., 2014; Kordi-Tamandani,
Tajoddini, & Salimi, 2015; Stolf et al., 2014). Some other
genes earlier shown to be associated with either addiction,
such as HTR2A (Cao et al., 2014; Perez-Rubio et al., 2017),
CNR1 (Clarke et al., 2013; Icick et al., 2015), contactin-
associated protein-like 2 (CNTNAP2; Song & Zhang, 2014)
and TNF (Heberlein et al., 2014), or with other psychiatric
conditions, such as AADAC (Bertelsen et al., 2016), ACP1
(Willour et al., 2012), IL1RN (Kapelski et al., 2016), IMMP2L
(Petek et al., 2001), LHX6 (Paschou et al., 2012), MEIS1
(Hammerschlag et al., 2017), MIR302A (Beveridge, Gardiner,
Carroll, Tooney, & Cairns, 2010), NTN4 (Paschou et al.,
2014), and SLITRK1 (Abelson et al., 2005; Speed et al., 2008)
were also included. It has been shown that microRNAs
(miRNAs) regulate multiple signaling cascades implicated in
several types of addictive disorders (Bali & Kenny, 2013; Sim
et al., 2017; Smith & Kenny, 2017). Since the 3′ UTR of a
gene serves for binding of various miRNAs, a polymorphism
in these sequences might alter the binding afﬁnity of regulatory
miRNAs to their target messenger RNAs, therefore inﬂuenc-
ing the expression of the given gene.
We hypothesized that variants potentially affecting
miRNA-directed regulation of gene expression may serve
as risk factors for behavioral addictions, such as gambling.
MATERIALS AND METHODS
Participants
Samples were collected from individuals residing in Shil-
long, Meghalaya, located in the North Eastern region of
India. The study includes only those individuals whose
pedigree can be traced back for three or more consecutive
generations. Thus, 196 unrelated adults (130 males, 66
females, mean age: 27.56± 9.139 years) from the Indo-
Aryan linguistic group were included in the study. Out of the
total sample of 196 individuals, 96 were gamblers (49%)
and 100 were non-gamblers (51%) and hence were consid-
ered as negative control.
Phenotype measures
The gambling phenotype was determined using the Problem
Gambling Severity Index (PGSI). The PGSI classiﬁes the
gamblers in four categories: non-problem gambler, low-risk
gambler, moderate-risk gambler, and problem gambler. The
PGSI was submitted to the participants of the study; the
answers were recorded and the gamblers were grouped
according to the PGSI parameters. In this study, 5.4% were
non-problem gamblers, 12% were low-risk gamblers, 39.1%
were moderate-risk gamblers, and 43.5% were problem
gamblers. The following parameters were assessed: frequen-
cy of gambling, amount of money gambled (from 25 to
15,000 Indian Rupees a day), attitude of the participants, etc.
For the statistical analysis in this study, participants were
grouped into two categories: gamblers and non-gamblers.
The non-gamblers, representing the negative control group,
reported no lifetime gambling history.
The SNP selection criteria
SNPs with a minor allele frequency (MAF) greater than 0.05
were selected from the Single Nucleotide Polymorphism
Database (http://www.ncbi.nlm.nih.gov/SNP) of the National
Centre for Biotechnology Information. The pairwise tagging
method using the linkage disequilibrium r2 threshold of 0.8
by the HaploView Program (Barrett, Fry, Maller, & Daly,
2005) was used to determine tagging SNPs based on HapMap
data to obtain a proper coverage of the GDNF gene. In case of
a number of options for tagging SNPs, a reference from
previous association studies concerning neuropsychiatric
disorders was preferred. We selected the following GDNF
SNPs: rs3812047, rs11111, rs3096140, rs1549250, and
rs2973033.
Table 1 presents the studied SNPs from the 3′ UTR
region of additional candidate genes implicated in addiction
and other psychiatric disorders. SNPs selection was
preceded by in silico searches using several miRNA data-
bases to identify SNPs predicted to alter miRNA binding
within the 3′ UTR, therefore, more likely to be a risk factor
for the phenotype.
Sample preparation and SNP genotyping
Collection of samples and isolation of genomic DNA from
buccal swabs were carried out as described previously
(Boor et al., 2002). Concentration of the extracted DNA
was measured using NanoDrop™ 1000 (Thermo Fisher
Scientiﬁc, Waltham, MA, USA).
Genotyping procedure
Genotyping of the GDNF gene (real-time PCR).Genotyping
was carried out on the real-time cycler ABI Prism 7300
Real-Time PCR System (Thermo Fisher Scientiﬁc). Five
SNPs of the GDNF gene located in chromosome position
5p12–p13.1 were genotyped using pre-designed TaqMan®
kits with FAM and VIC ﬂuorescent probes: rs3812047
(C_27492935_10), rs11111 (C_8813050_1_), rs1549250
(C_11553504_10), rs3096140 (C_1395038_20), and
rs2973033 (C_15958567_10).
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OpenArray SNPs genotyping. Genotyping of SNPs men-
tioned in Table 1 was performed on a TaqMan®
OpenArray® Genotyping System (Thermo Fisher Scientif-
ic). The processing of raw data was performed using
TaqMan® Genotyping Software (Thermo Fisher Scientiﬁc).
We regenotyped 10% of samples as a quality control step to
avoid any batch effects. Out of the 32 SNPs considered for
assessment, 27 SNPs were successfully genotyped. Out of
the 5 SNPs not included in the statistical analysis, three were
non-successfully genotyped (rs41557622 of SLITRK1;
rs1062072 and rs2530310 of CNTNAP2) and two were
found to be non-polymorphic (rs72824830 of MEIS1 and
rs4252041 of IL1R).
Statistical analyses
Standard case–control association analysis was performed
using SPSS 20.0 (SPSS Inc., Chicago, IL, USA). The
p values <.05 were considered nominally signiﬁcant. Cor-
rection for multiple testing was made according to the
Bonferroni method: the threshold signiﬁcance was
adjusted to p< .0015625 where .0015625= .05/32 (since
5+ 27= 32 SNPs, genotyped by the two different methods,
were used for the ﬁnal statistical analysis). We applied the
most stringent Bonferroni correction for multiple testing to
rule out type I errors in null hypothesis testing. In order to
estimate the statistical power of our pilot sample, we
performed a post-hoc power calculation using the G*Power
software (Faul, Erdfelder, Lang, & Buchner, 2007) to
determine the necessary sample size to ﬁnd signiﬁcant
genetic effects. With a 0.1 effect size (partial eta square
value by two groups), by a power set to be at least 0.80, it
was determined that 964 participants would be needed in the
total sample to detect such an association.
Ethics
The study protocol was approved by the Departmental
Research Committee (DRC) of the School of Human
Sciences, North Eastern Hill University. Written informed
consent was obtained from all participating individuals.
RESULTS
Real-time PCR genotyping results
MAFs of the GDNF SNPs in this study were compared to
other Asian population from the HapMap Project (http://
www.ncbi.nlm.nih.gov). No signiﬁcant deviation was
observed from the MAFs of Asian population.
A case–control study was conducted to explore possible
association of various GDNF gene SNPs with gambling
(Table 2). Table 3 shows the results of χ2 tests of genotype
distribution differences between cases and controls,
numbers, and percentages of individuals in each genotype
group for (a) non-gamblers (control individuals with no
history of gambling) and (b) gamblers. We observed nomi-
nally signiﬁcant differences in case of rs2973033
(p= .00027, χ2= 16.391, df= 2), rs3812047 (p= .00314,
χ2= 8.719, df= 1) and rs1549250 (p= .045, χ2= 6.191,
df= 2). After correcting for multiple testing, only rs2973033
remained signiﬁcant (corrected p= .00864).
In case of GDNF SNP rs1549250, the AA and CC
genotypes showed higher frequency in case of the non-
gamblers (18% and 51%, respectively) compared to those
who gambled (13.7% and 37.9%, respectively). In contrast,
the frequency of heterozygote AC was higher in individuals
who gambled (48.4%) compared to those who never
gambled (31%). In case of GDNF SNP rs3812047, the
frequency of the CT genotype was higher in gamblers
Table 1. SNPs investigated with the OpenArray genotyping system
Gene Gene name SNP
AADAC Arylacetamide deacetylase rs1042201
ACP1 Acid phosphatase 1, soluble rs6855
CNR1 Cannabinoid receptor 1 rs4707436
rs806368
CNTNAP2 Contactin-associated protein-like 2 rs1062072
rs2530310
rs2530311
rs987456
COMT Catechol-O-methyltransferase rs165599
rs165728
DRD2 Dopamine receptor D2 rs6276
rs6278
GDNF Glial cell-derived neurotrophic
factor
rs2973051
rs3749692
rs62360370
HTR2A 5-Hydroxytryptamine receptor 2A rs3125
IL1RN Interleukin 1 receptor antagonist rs4252041
IMMP2L Inner mitochondrial membrane
peptidase subunit 2
rs1044729
rs17158195
rs7795011
LHX6 LIM homeobox 6 rs3750486
rs74370188
MAOA monoamine oxidase A rs3027407
MEIS1 Meis homeobox 1 rs72824830
MIR302A rs114318553
NTN4 Netrin 4 rs1052651
rs8699
SLC6A3 Solute carrier family 6 member 3 rs11564774
rs7732456
SLITRK1 SLIT- and NTRK-like family
member 1
rs3737193
rs41557622
TNF Tumor necrosis factor rs3093665
Note. SNP: single nucleotide polymorphism.
Table 2. Location of the real-time PCR-analyzed genetic variants in
the vicinity of the GDNF gene
SNP Location within the gene
rs2973033 5′ UTR
rs3096140 Intron
rs3812047 Intron
rs1549250 Intron
rs11111 3′ UTR
Note. SNP: single nucleotide polymorphism; PCR: polymerase
chain reaction; GDNF: glial cell line-derived neurotrophic factor;
UTR: untranslated region.
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(20.2%) than non-gamblers (6%), suggesting a protective
role for the more common CC genotype (the TT homozy-
gous genotype was absent from both groups in our sample).
Nevertheless, the above results did not survive Bonferroni
correction for multiple testing.
When looking at rs2973033, we observed that the
frequency of CT and TT genotypes is higher in case of
gamblers (62.4% and 23.7%, respectively) compared to
non-gamblers (44% and 16%, respectively). The result
suggests that the CT and TT genotypes might serve as risk
factors, whereas the CC genotype could be protective
against gambling (p= .00027, χ2= 16.391, df= 2). The
association of rs2979033 with gambling remained statisti-
cally signiﬁcant after Bonferroni correction for multiple
testing (corrected p= .00864).
OpenArray genotyping results
Table 4 shows the top hits (p< .05) of the case–control
analysis involving the 3′ UTR SNPs genotyped on the
OpenArray platform; detailed results of the successfully
genotyped SNPs are available in Supplementary Table
S1. SNP rs74370188 in the LHX6 gene showed a nominally
signiﬁcant (p= .01571, χ2= 5.834, df= 1) association in the
χ2 test. The frequency of the most prevalent GG genotype is
higher in non-gamblers (78.0%) than in gamblers (61.7%).
However, rs74370188 does not survive the Bonferroni
correction for multiple testing.
In the case of rs2530311 located in CNTNAP2 gene, we
observed a signiﬁcant association (p= .00140, χ2= 13.132,
df= 2) in the χ2 test, which withstands correction for
Table 3. The case–control analysis of any form of gambling and GDNF SNPs
Non-gamblers Gamblers
GDNF SNP Genotype N % N % p Corrected p value χ2
rs2973033 CC 40 40 13 14 .00027** .00864 16.391
TT 16 16 22 23.7
CT 44 44 58 62.4
Total 100 93
rs3096140 AA 52 60.5 51 56.7 .444 1 1.623
GG 9 10.5 6 6.7
AG 25 29.1 33 36.7
Total 86 90
rs3812047 CC 94 94 75 79.8 .00314* .10048 8.719
TT – – – –
CT 6 6 19 20.2
Total 100 94
rs1549250 AA 18 18 13 13.7 .045* 1 6.191
CC 51 51 36 37.9
AC 31 31 46 48.4
Total 100 95
rs11111 CC 8 8.1 4 4.2 .286 1 2.504
TT 66 66.7 59 62.1
CT 25 25.3 32 33.7
Total 99 95
Note. χ2: chi-square value; p: p value with .05 signiﬁcance level; SNP: single nucleotide polymorphism; GDNF: glial cell line-derived
neurotrophic factor.
*Nominally signiﬁcant (p< .05). **Signiﬁcant after multiple correction (p< .001).
Table 4. The top two SNPs (p< .05) of the case–control analysis of any form of gambling and SNPs in 3′ UTR: OpenArray results
Non-gamblers Gamblers
Genotype N % N % p Corrected p value χ2 OR
CNTNAP2
rs2530311 AA 21 23.9 41 47.7 .00140** .0448 13.132 NA
GG 19 21.6 7 8.1
AG 48 54.5 38 44.2
Total 88 86
LHX6
rs74370188 AA – – – – .01571* .5072 5.834 0.454
GG 71 78 58 61.7
AG 20 22 36 38.3
Total 91 94
Note. χ2: Chi-square value; OR: odds ratio; UTR: untranslated region; SNP: single nucleotide polymorphism; NA: not applicable; p: p value
with .05 signiﬁcance level.
*Nominally signiﬁcant (p< .05). **Signiﬁcant after multiple correction (p< .001).
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multiple testing (corrected p= .0448). The frequency of the
AA genotype of rs2530311 is higher in case of gamblers
(47.7%) compared to non-gamblers (23.9%). Thus, the AA
genotype seems to be the risk factor for gambling.
DISCUSSION
This study was conducted on a population of gamblers
involved in a local archery game in Meghalaya, India. The
traditional sport, commonly known as “teer,” has gained
widespread popularity among locals of Shillong in part
due to the high odds offered by the organizers, allowing
winners to take home 80 times the sum that was gambled.
Our case–control genetic analysis identiﬁed two signiﬁ-
cant associations between gambling and the GDNF gene
SNP rs2973033 (p= .00864, χ2= 16.391, df= 2) and the
CNTNAP2 gene SNP rs2530311 (p= .0448, χ2= 13.132,
df= 2) after correction for multiple testing.
GDNF is a well-studied gene associated with addiction
and plays a role in several processes including drug reward,
drug self-administration, relapse, and abstinence (Ghitza
et al., 2010; Wise, 2004). The gene encodes a secreted
ligand of the transforming growth factor-beta (TGF-β)
receptor superfamily of proteins. Upon ligand binding to
various TGF-β receptors, transcription factors of the SMAD
family are recruited and activated, resulting in gene expres-
sion changes. GDNF is involved in the growth, survival, and
morphological differentiation of dopaminergic neurons dur-
ing development as well as enhanced high-afﬁnity uptake of
dopamine in rat embryonic midbrain cells (Lin, Doherty,
Lile, Bektesh, & Collins, 1993). The role of GDNF in
reward mechanisms has been shown in animal model
studies with drugs like cocaine, methamphetamine, and
alcohol (Ghitza et al., 2010). Moreover, external injection
of GDNF in rats was shown to reduce the impact of
dopamine depletion observed during drug abstinence
(Barak, Carnicella, Yowell, & Ron, 2011). A GDNF knock-
out study in mice has also shown increased sensitivity for
alcohol in case of heterozygotes compared to wild-type
homozygotes, thus conﬁrming the role of endogenous
GDNF in reducing the rewarding effects of ethanol
(Carnicella, Ahmadiantehrani, Janak, & Ron, 2009). In a
previous study conducted by our group, strong association
was observed between GDNF SNPs rs3812047 and rs11111
with nicotine and betel quid use (unpublished data).
In this study, we report a signiﬁcant association of
rs2973033 in GDNF with game-based gambling. Our results
conﬁrm the role of GDNF in addiction, and to our knowl-
edge, this is the ﬁrst study to show association of GDNF
gene polymorphisms with gambling as a type of behavioral
addiction.
The CNTNAP2 gene codes for a neuronal transmem-
brane protein belonging to the neurexin superfamily
involved in communication between neuronal cells (Condro
&White, 2014). This protein is also involved in localization
of potassium channels within differentiating axons (Poliak
et al., 1999). The gene encompasses almost 1.5% of
chromosome 7 and is one of the largest genes in the human
genome. Due to its large extent, it is likely a target
for structural rearrangements, including copy number
variations, translocations, altered transcription factor bind-
ing, and also epigenetic modiﬁcations, including miRNA
regulation. The CNTNAP2 gene has been implicated in
several neurodevelopmental disorders. Due to a transloca-
tion affecting the coding region of the gene, it was found to
be associated with Gilles de la Tourette syndrome, intellec-
tual disability, and obsessive–compulsive disorder (Verkerk
et al., 2003). Other cognitive disorders, such as schizophre-
nia, epilepsy, autism, and attention-deﬁcit hyperactivity
disorder, were also linked to disruptions in CNTNAP2 gene
(Rodenas-Cuadrado, Ho, & Vernes, 2014). SNP variants of
this gene were also linked to various complex neurological
disorders including autism (Alarcon et al., 2008; Arking
et al., 2008; Strauss et al., 2006), schizophrenia, and
depression (Ji et al., 2013). CNTNAP2 gene was previously
identiﬁed in alcohol addiction (Song & Zhang, 2014). The
study used a new computational method, tree-based analysis
of rare variants, to investigate the effect of rare variants in
complex disorders. The authors suggested that 97 rare
variants of the CNTNAP2 gene could be protective against
alcohol addiction in women. In this study, we found that the
common variant rs2530311 of the CNTNAP2 gene is
associated with gambling, thus corroborating the involve-
ment of this gene in the addiction behavior.
The main limitation of the study is the relatively small
sample size. However, this is a pilot study performed with a
very unique, culturally distinct phenotype and even this
collection has proven to be a great challenge. Thus, our ﬁnal
sample consisted of 196 participants, on which the explor-
atory genetic association analysis was conducted.
In conclusion, to our knowledge, this is the ﬁrst study
reporting a direct link between CNTNAP2 and game-based
gambling. This study further conﬁrms the role of GDNF in
addiction, while it is the ﬁrst study to show the association
of GDNF polymorphism with gambling as a type of
behavioral addiction.
Funding sources: AD was supported by Hungarian Schol-
arship Board Indian-Hungarian collaboration Scheme B
Postgraduate program, 2014-2015: “Study on the genetic
variants in gambling.” LP was ﬁnanced by FP7-People-
2012-ITN, project: TS-Eurotrain, grant number 316978. CB
was supported by funding from the Merit-prize fellowship
of Semmelweis University, the Bolyai János research fel-
lowship of the Hungarian Academy of Sciences BO/00987/
16/5; the ÚNKP-18-4 of the new National Excellence
Program of the Ministry of Human Capacities; and the
Baron Munchausen Program of the Institute of Medical
Chemistry, Molecular Biology and Pathobiochemistry,
Semmelweis University. The study was also supported by
the Hungarian National Research, Development and Inno-
vation Ofﬁce (grant numbers: K111938 and KKP126835).
The study was completed with the support of the Hungarian
Ministry of Human Capacities (ELTE Institutional Excel-
lence Program, 783-3/2018/FEKUTSRAT).
Authors’ contribution: AD and BL collected the samples.
AD, LP, AV, and CB performed the DNA extraction
and genotyping. AD, LP, AV, and EK carried out the
statistical analyses. All authors have contributed to the ﬁnal
Journal of Behavioral Addictions 8(3), pp. 471–478 (2019) | 475
Gene variants in gambling
draft of the manuscript. AD and LP contributed equally to
this work.
Conﬂict of interest: The authors declare no conﬂict of
interest.
Acknowledgements: The authors would particularly like to
thank all participants who took part in this study. They
would also like to thank Ms. Cynthia Hunn for her kind
assistance in editing the manuscript.
REFERENCES
Abelson, J. F., Kwan, K. Y., O’Roak, B. J., Baek, D. Y., Stillman,
A. A., Morgan, T. M., Mathews, C. A., Pauls, D. L., Rasin,
M. R., Gunel, M., Davis, N. R., Ercan-Sencicek, A. G., Guez,
D. H., Spertus, J. A., Leckman, J. F., Dure, L. S., Kurlan, R.,
Singer, H. S., Gilbert, D. L., Farhi, A., Louvi, A., Lifton, R. P.,
Sestan, N., & State, M. W. (2005). Sequence variants in
SLITRK1 are associated with Tourette’s syndrome. Science,
310(5746), 317–320. doi:10.1126/science.1116502
Alarcon, M., Abrahams, B. S., Stone, J. L., Duvall, J. A., Perederiy,
J. V., Bomar, J. M., Sebat, J., Wigler, M., Martin, C. L.,
Ledbetter, D. H., Nelson, S. F., Cantor, R. M., & Geschwind,
D. H. (2008). Linkage, association, and gene-expression anal-
yses identify CNTNAP2 as an autism-susceptibility gene.
American Journal of Human Genetics, 82(1), 150–159.
doi:10.1016/j.ajhg.2007.09.005
American Psychiatric Association. (2013). Diagnostic and
statistical manual of mental disorders (5th ed.). Washington,
DC: American Psychiatric Association.
Arking, D. E., Cutler, D. J., Brune, C. W., Teslovich, T. M., West,
K., Ikeda, M., Rea, A., Guy, M., Lin, S., Cook, E. H., &
Chakravarti, A. (2008). A common genetic variant in the
neurexin superfamily member CNTNAP2 increases familial
risk of autism. American Journal of Human Genetics, 82(1),
160–164. doi:10.1016/j.ajhg.2007.09.015
Bali, P., & Kenny, P. J. (2013). MicroRNAs and drug addiction.
Frontiers in Genetics, 4, 43. doi:10.3389/fgene.2013.00043
Barak, S., Carnicella, S., Yowell, Q. V., & Ron, D. (2011). Glial
cell line-derived neurotrophic factor reverses alcohol-induced
allostasis of the mesolimbic dopaminergic system: Implica-
tions for alcohol reward and seeking. Journal of Neuroscience,
31(27), 9885–9894. doi:10.1523/JNEUROSCI.1750-11.2011
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005). Haploview:
Analysis and visualization of LD and haplotype maps. Bioin-
formatics, 21(2), 263–265. doi:10.1093/bioinformatics/bth457
Bertelsen, B., Stefansson, H., Jensen, L. R., Melchior, L., Debes,
N. M., Groth, C., Skov, L., Werge, T., Karagiannidis, I.,
Tarnok, Z., & Barta, C. (2016). Association of AADAC
deletion and Gilles de la Tourette Syndrome in a large
European cohort. Biological Psychiatry, 79(5), 383–391.
doi:10.1016/j.biopsych.2015.08.027
Beveridge, N. J., Gardiner, E., Carroll, A. P., Tooney, P. A., &
Cairns, M. J. (2010). Schizophrenia is associated with an
increase in cortical microRNA biogenesis. Molecular
Psychiatry, 15(12), 1176–1189. doi:10.1038/mp.2009.84
Boor, K., Ronai, Z., Nemoda, Z., Gaszner, P., Sasvari-Szekely, M.,
Guttman, A., & Kalasz, H. (2002). Noninvasive genotyping of
dopamine receptor D4 (DRD4) using nanograms of DNA from
substance-dependent patients. Current Medicinal Chemistry,
9(8), 793–797. doi:10.2174/0929867024606821
Cao, J., Liu, X. T., Han, S. Z., Zhang, C. K., Liu, Z. Z., & Li, D. W.
(2014). Association of the HTR2A gene with alcohol and
heroin abuse. Human Genetics, 133(3), 357–365. doi:10.1007/
s00439-013-1388-y
Carnicella, S., Ahmadiantehrani, S., Janak, P. H., & Ron, D.
(2009). GDNF is an endogenous negative regulator of
ethanol-mediated reward and of ethanol consumption after a
period of abstinence. Alcoholism-Clinical and Experimental
Research, 33(6), 1012–1024. doi:10.1111/j.1530-0277.2009.
00922.x
Clarke, T. K., Bloch, P. J., Ambrose-Lanci, L. M., Ferraro, T. N.,
Berrettini, W. H., Kampman, K. M., Dackis, C. A., Pettinati,
H. M., O’Brien, C. P., Oslin, D. W., & Lohoff, F. W. (2013).
Further evidence for association of polymorphisms in the
CNR1 gene with cocaine addiction: Conﬁrmation in an inde-
pendent sample and meta-analysis. Addiction Biology, 18(4),
702–708. doi:10.1111/j.1369-1600.2011.00346.x
Condro, M. C., & White, S. A. (2014). Distribution of language-
related Cntnap2 protein in neural circuits critical for vocal
learning. The Journal of Comparative Neurology, 522(1),
169–185. doi:10.1002/cne.23394
Fagundo, A. B., Fernandez-Aranda, F., de la Torre, R., Verdejo-
Garcia, A., Granero, R., Penelo, E., Gené, M., Barrot, C.,
Sánchez, C., Alvarez-Moya, E., & Ochoa, C. (2014). Dopa-
mine DRD2/ANKK1 Taq1A and DAT1 VNTR polymorph-
isms are associated with a cognitive ﬂexibility proﬁle in
pathological gamblers. Journal of Psychopharmacology,
28(12), 1170–1177. doi:10.1177/0269881114551079
Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007).
G*Power 3: A ﬂexible statistical power analysis program for
the social, behavioral, and biomedical sciences. Behavior
Research Methods, 39(2), 175–191. doi:10.3758/BF03193146
Ghitza, U. E., Zhai, H. F., Wu, P., Airavaara, M., Shaham, Y., &
Lu, L. (2010). Role of BDNF and GDNF in drug reward and
relapse: A review. Neuroscience and Biobehavioral Reviews,
35(2), 157–171. doi:10.1016/j.neubiorev.2009.11.009
Grant, J. E., Leppink, E. W., Redden, S. A., Odlaug, B. L., &
Chamberlain, S. R. (2015). COMT genotype, gambling activi-
ty, and cognition. Journal of Psychiatric Research, 68,
371–376. doi:10.1016/j.jpsychires.2015.04.029
Grant, J. E., Potenza, M. N., Weinstein, A., & Gorelick, D. A.
(2010). Introduction to behavioral addictions. American
Journal of Drug and Alcohol Abuse, 36(5), 233–241.
doi:10.3109/00952990.2010.491884
Guillot, C. R., Fanning, J. R., Liang, T. B., & Berman, M. E.
(2015). COMT associations with disordered gambling and
drinking measures. Journal of Gambling Studies, 31(2),
513–524. doi:10.1007/s10899-013-9434-1
Gyollai, A., Grifﬁths, M. D., Barta, C., Vereczkei, A., Urban, R.,
Kun, B., Kokonyei, G., Székely, A., Sasvári-Székely, M.,
Blum, K., & Demetrovics, Z. (2014). The genetics of problem
and pathological gambling: A systematic review. Current
Pharmaceutical Design, 20(25), 3993–3999. doi:10.2174/
13816128113199990626
Hammerschlag, A. R., Stringer, S., de Leeuw, C. A., Sniekers, S.,
Taskesen, E., Watanabe, K., Blanken, T. F., Dekker, K., Te
Lindert, B. H., Wassing, R., & Jonsdottir, I. (2017). Genome-
wide association analysis of insomnia complaints identiﬁes risk
476 | Journal of Behavioral Addictions 8(3), pp. 471–478 (2019)
Das et al.
genes and genetic overlap with psychiatric and metabolic traits.
Nature Genetics, 49(11), 1584–1592. doi:10.1038/ng.3888
Heberlein, A., Kaser, M., Lichtinghagen, R., Rhein, M., Lenz, B.,
Kornhuber, J., Bleich, S., & Hillemacher, T. (2014).
TNF-alpha and IL-6 serum levels: Neurobiological markers
of alcohol consumption in alcohol-dependent patients?
Alcohol, 48(7), 671–676. doi:10.1016/j.alcohol.2014.08.003
Hillemacher, T., Bleich, S., Frieling, H., Buchholz, V., Hussein, R.,
Meyer, C., Meyer, C., John, U., Bischof, A., & Rumpf, H. J.
(2016). Dopamine-receptor 2 gene-methylation and gambling
behavior in relation to impulsivity. Psychiatry Research, 239,
154–155. doi:10.1016/j.psychres.2016.03.021
Ibanez, A., Perez de Castro, I., Fernandez-Piqueras, J., Blanco, C.,
& Saiz-Ruiz, J. (2000). Pathological gambling and DNA
polymorphic markers at MAO-A and MAO-B genes. Molecu-
lar Psychiatry, 5(1), 105–109. doi:10.1038/sj.mp.4000654
Icick, R., Peoc’h, K., Karsinti, E., Ksouda, K., Hajj, A., Bloch, V.,
Prince, N., Mouly, S., Bellivier, F., Lépine, J. P., & Laplanche,
J. L. (2015). A Cannabinoid receptor 1 polymorphism is
protective against major depressive disorder in methadone-
maintained outpatients. American Journal on Addictions,
24(7), 613–620. doi:10.1111/ajad.12273
Ji, W., Li, T., Pan, Y., Tao, H., Ju, K., Wen, Z., Fu, Y., An, Z.,
Zhao, Q., Wang, T., & He, L. (2013). CNTNAP2 is signiﬁ-
cantly associated with schizophrenia and major depression in
the Han Chinese population. Psychiatry Research, 207(3),
225–228. doi:10.1016/j.psychres.2012.09.024
Joutsa, J., Hirvonen, M. M., Arponen, E., Hietala, J., & Kaasinen,
V. (2014). DRD2-related TaqIA genotype is associated with
dopamine release during a gambling task. Journal of Addiction
Medicine, 8(4), 294–295. doi:10.1097/ADM.00000000000
00037
Kapelski, P., Skibinska, M., Maciukiewicz, M., Pawlak, J.,
Dmitrzak-Weglarz, M., Szczepankiewicz, A., Zaremba, D.,
& Twarowska-Hauser, J. (2016). An association between
functional polymorphisms of the interleukin 1 gene complex
and schizophrenia using transmission disequilibrium test.
Archivum Immunologiae et Therapiae Experimentalis,
64(Suppl. 1), 161–168. doi:10.1007/s00005-016-0434-6
Kordi-Tamandani, D. M., Tajoddini, S., & Salimi, F. (2015).
Promoter methylation and BDNF and DAT1 gene expression
proﬁles in patients with drug addiction. Pathobiology, 82(2),
94–99. doi:10.1159/000430465
Kotyuk, E., Nemeth, N., Ronai, Z., Demetrovics, Z.,
Sasvari-Szekely, M., & Szekely, A. (2016). Association
between smoking behaviour and genetic variants of glial cell
line-derived neurotrophic factor. Journal of Genetics, 95(4),
811–818. doi:10.1007/s12041-016-0701-7
Lin, L. F., Doherty, D. H., Lile, J. D., Bektesh, S., & Collins, F.
(1993). GDNF: A glial cell line-derived neurotrophic factor for
midbrain dopaminergic neurons. Science, 260(5111),
1130–1132. doi:10.1126/science.8493557
Paschou, P., Stylianopoulou, E., Karagiannidis, I., Rizzo, R.,
Tarnok, Z., Wolanczyk, T., Hebebrand, J., Nöthen, M. M.,
Lehmkuhl, G., Farkas, L., & Nagy, P. (2012). Evaluation of the
LIM homeobox genes LHX6 and LHX8 as candidates for
Tourette syndrome. Genes, Brain, and Behavior, 11(4),
444–451. doi:10.1111/j.1601-183X.2012.00778.x
Paschou, P., Yu, D., Gerber, G., Evans, P., Tsetsos, F., Davis,
L. K., Karagiannidis, I., Chaponis, J., Gamazon, E.,
Mueller-Vahl, K., & Stuhrmann, M. (2014). Genetic
association signal near NTN4 in Tourette syndrome. Annals
of Neurology, 76(2), 310–315. doi:10.1002/ana.24215
Perez-Rubio, G., Ramirez-Venegas, A., Diaz, V. N., Gomez, L. G.,
Fabian, K. E., Carmona, S. G., Lo´pez-Flores, L. A., Ambrocio-
Ortiz, E., Romero, R. C., Alcantar-Ayala, N., & Sansores,
R. H. (2017). Polymorphisms in HTR2A and DRD4
predispose to smoking and smoking quantity. PLoS One,
12(1), e0170019. doi:10.1371/journal.pone.0170019
Petek, E., Windpassinger, C., Vincent, J. B., Cheung, J., Boright,
A. P., Scherer, S. W., Kroisel, P. M., & Wagner, K. (2001).
Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31
associated with Tourette syndrome. American Journal of Hu-
man Genetics, 68(4), 848–858. doi:10.1086/319523
Poliak, S., Gollan, L., Martinez, R., Custer, A., Einheber, S.,
Salzer, J. L., Trimmer, J. S., Shrager, P., & Peles, E.
(1999). Caspr2, a new member of the neurexin superfamily,
is localized at the juxtaparanodes of myelinated axons and
associates with K+ channels. Neuron, 24(4), 1037–1047.
doi:10.1016/S0896-6273(00)81049-1
Robbins, T. W., & Clark, L. (2015). Behavioral addictions.
Current Opinion in Neurobiology, 30, 66–72. doi:10.1016/
j.conb.2014.09.005
Rodenas-Cuadrado, P., Ho, J., & Vernes, S. C. (2014). Shining a
light on CNTNAP2: Complex functions to complex disorders.
European Journal of Human Genetics, 22(2), 171–178.
doi:10.1038/ejhg.2013.100
Ron, D., & Janak, P. H. (2005). GDNF and addiction. Reviews
in the Neurosciences, 16(4), 277–285. doi:10.1515/
REVNEURO.2005.16.4.277
Shaffer, H. J., Hall, M. N., & Vander Bilt, J. (1999). Estimating the
prevalence of disordered gambling behavior in the United
States and Canada: A research synthesis. American Journal
of Public Health, 89(9), 1369–1376. doi:10.2105/AJPH.
89.9.1369
Sim, M. S., Soga, T., Pandy, V., Wu, Y. S., Parhar, I. S., &
Mohamed, Z. (2017). MicroRNA expression signature of
methamphetamine use and addiction in the rat nucleus
accumbens. Metabolic Brain Disease, 32(6), 1767–1783.
doi:10.1007/s11011-017-0061-x
Smith, A. C. W., & Kenny, P. J. (2017). MicroRNAs regulate
synaptic plasticity underlying drug addiction. Genes, Brain,
and Behavior, 17(3), e12424. doi:10.1111/gbb.12424
Song, C., & Zhang, H. P. (2014). TARV: Tree-based analysis of
rare variants identifying risk modifying variants in CTNNA2
and CNTNAP2 for alcohol addiction. Genetic Epidemiology,
38(6), 552–559. doi:10.1002/gepi.21843
Speed, W. C., O’Roak, B. J., Tarnok, Z., Barta, C., Pakstis, A. J.,
State, M. W., & Kidd, K. K. (2008). Haplotype evolution of
SLITRK1, a candidate gene for Gilles de la Tourette syndrome.
American Journal of Medical Genetics Part B-Neuropsychiatric
Genetics, 147B(4), 463–466. doi:10.1002/ajmg.b.30641
Stolf, A. R., Szobot, C. M., Halpern, R., Akutagava-Martins, G. C.,
Muller, D., Guimaraes, L. S. P., Kessler, F. H., Pechansky, F.,
& Roman, T. (2014). Crack cocaine users show differences in
genotype frequencies of the 3′ UTR variable number of tandem
repeats of the dopamine transporter gene (DAT1/SLC6A3).
Neuropsychobiology, 70(1), 44–51. doi:10.1159/000365992
Strauss, K. A., Puffenberger, E. G., Huentelman, M. J.,
Gottlieb, S., Dobrin, S. E., Parod, J. M., Stephan, D. A., &
Morton, D. H. (2006). Recessive symptomatic focal epilepsy
and mutant contactin-associated protein-like 2. The New
Journal of Behavioral Addictions 8(3), pp. 471–478 (2019) | 477
Gene variants in gambling
England Journal of Medicine, 354(13), 1370–1377.
doi:10.1056/NEJMoa052773
Verdejo-Garcia, A., Fagundo, A. B., Cuenca, A., Rodriguez, J.,
Cuyas, E., Langohr, K., de Sola Llopis, S., Civit, E., Farré, M.,
Pen˜a-Casanova, J., & de la Torre, R. (2013). COMT val158met
and 5-HTTLPR genetic polymorphisms moderate executive
control in Cannabis users. Neuropsychopharmacology, 38(8),
1598–1606. doi:10.1038/npp.2013.59
Verkerk, A. J., Mathews, C. A., Joosse, M., Eussen, B. H.,
Heutink, P., Oostra, B. A., & Tourette Syndrome Association
International Consortium for Genetics. (2003). CNTNAP2 is
disrupted in a family with Gilles de la Tourette syndrome and
obsessive compulsive disorder. Genomics, 82(1), 1–9.
doi:10.1016/S0888-7543(03)00097-1
Welte, J. W., Barnes, G. M., Tidwell, M. C. O., Hoffman, J. H., &
Wieczorek, W. F. (2015). Gambling and problem gambling in
the United States: Changes between 1999 and 2013. Journal of
Gambling Studies, 31(3), 695–715. doi:10.1007/s10899-014-
9471-4
Willour, V. L., Seifuddin, F., Mahon, P. B., Jancic, D., Pirooznia,
M., Steele, J., Schweizer, B., Goes, F. S., Mondimore, F. M.,
Mackinnon, D. F., Bipolar Genome Study Consortium, Perlis,
R. H., Lee, P. H., Huang, J., Kelsoe, J. R., Shilling, P. D.,
Rietschel, M., Nöthen, M., Cichon, S., Gurling, H., Purcell, S.,
Smoller, J. W., Craddock, N., DePaulo, J. R., Jr., Schulze,
T. G., McMahon, F. J., Zandi, P. P., & Potash, J. B. (2012). A
genome-wide association study of attempted suicide. Molecu-
lar Psychiatry, 17(4), 433–444. doi:10.1038/mp.2011.4
Wise, R. A. (2004). Dopamine, learning and motivation.
Nature Reviews Neuroscience, 5(6), 483–494. doi:10.1038/
nrn1406
Xuan, Y. H., Li, S., Tao, R., Chen, J., Rao, L. L., Wang, X. T., &
Zheng, R. (2017). Genetic and environmental inﬂuences on
gambling: A meta-analysis of twin studies. Frontiers in
Psychology, 8, 2121. doi:10.3389/fpsyg.2017.02121
Yoshimura, T., Usui, H., Takahashi, N., Yoshimi, A., Saito, S.,
Aleksic, B., Ujike, H., Inada, T., Yamada, M., Uchimura, N.,
Iwata, N., Sora, I., Iyo, M., & Ozaki, N. (2011). Association
analysis of the GDNF gene with methamphetamine use
disorder in a Japanese population. Progress in Neuro-
Psychopharmacology & Biological Psychiatry, 35(5),
1268–1272. doi:10.1016/j.pnpbp.2011.04.003
478 | Journal of Behavioral Addictions 8(3), pp. 471–478 (2019)
Das et al.
